Industry News

Horizon Petroleum Ltd. ‎Closes First Tranche of Private Placement

/Not for distribution to U.S. Newswire Services or for dissemination in the United States of America. Any ‎failure to comply with this restriction may...

No easy way to communicate risks of climate change, new research finds

New research from the Singapore Management University shows that having individuals visualise the shock of future climate change failed to motivate them to change...

Planbox Named the Leader in the 2023 SPARK Matrix for Innovation Management by Quadrant Knowledge Solutions

The Quadrant Knowledge Solutions SPARK Matrix™ provides competitive analysis & ranking of the leading Innovation Management vendors.Planbox, with its comprehensive technology and customer experience...

National Police Federation Responds to Charges Against Some RCMP Members in Prince George, B.C.

VANCOUVER, BC, Feb. 1, 2023 /CNW/ - Following is a statement from Brian Sauvé, President, National Police Federation, regarding charges laid against some RCMP...

Vista Outdoor Announces Time Change for its Third Quarter Fiscal Year 2023 Earnings Release

Earnings Call Remains as Scheduled at 9:00 a.m. EST on February 2, 2023 ANOKA, Minn., Feb. 1, 2023 /PRNewswire/ -- Vista Outdoor Inc. (NYSE: VSTO), the...

LRQA gets approval for WSEP audits in Asia and Indian Subcontinent with Woolworths

BANGKOK, Feb. 2, 2023 /PRNewswire/ -- LQRA is delighted to announce the extension of their approval for Woolworths Supplier Excellence audits – Food in Asia and...

Food Recall Warning (Allergen) – Nutrifresh brand Falooda Drink with Almond Flavour recalled due to undeclared milk

Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/nutrifresh-brand-falooda-drink-almond-flavour-recalled-due-undeclared-milk OTTAWA, ON, Feb. 1, 2023 /CNW/ - SummaryBrand(s): NutrifreshProduct: Falooda Drink with Almond FlavourCompanies: Nutrifresh West Ltd.Issue: Food – Allergen –...

FDA Approves First Oral Treatment for Anemia Caused by Chronic Kidney Disease for Adults on Dialysis

SILVER SPRING, Md., Feb. 1, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Jesduvroq tablets (daprodustat) as the first oral treatment...

Latest articles

WeeklyReviewer